José A Guevara-Patiño

7PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jun 24, 2025
PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis.

Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska

|Feb 26, 2025
Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients.

Mate Z Nagy, Lourdes B Plaza-Rojas, Justin C Boucher

|Feb 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.

Surya Pandey, Meghan E Cholak, Rishita Yadali

|Jul 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.

Sachin R Jhawar, Shang-Jui Wang, Aditya Thandoni

|Jun 28, 2023
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma.

Ritu Chaudhary, Robbert J C Slebos, Leenil C Noel

Pageof 2

Frequent Collaborators

3 joint publications

Ritu Chaudhary

3 joint publications

Robbert J C Slebos

3 joint publications

Maria I Poole

3 joint publications

Christine H Chung